Vilin Bio Med Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	199.81	148.1	158.05	123.13	112.15	117.15
Other Revenue	-	-	-	0.24	0.04	0.04
Revenue	199.81	148.1	158.05	123.37	112.19	117.19
Revenue Growth (YoY)	52.70%	-6.30%	28.11%	9.97%	-4.26%	-30.34%
Cost of Revenue	186.79	134.9	130.31	72.64	89.77	90.39
Gross Profit	13.02	13.2	27.74	50.74	22.42	26.8
Selling, General & Admin	3.48	2.95	8.07	7.77	8.57	10.67
Other Operating Expenses	2.53	2.38	11.51	16.99	6.15	7.53
Operating Expenses	7.05	6.38	20.88	26.44	16.92	20.77
Operating Income	5.97	6.83	6.87	24.3	5.51	6.03
Interest Expense	-5.04	-8.45	-7.8	-6.49	-4.95	-4.15
Interest & Investment Income	4.69	4.69	3.24	-	-	-
Other Non Operating Income (Expenses)	-2.16	-0	-0.05	0	-0.11	-0.27
Pretax Income	3.46	3.06	2.25	17.82	0.45	1.61
Income Tax Expense	0.95	0.82	0.63	5.37	0.11	0.4
Net Income	2.51	2.24	1.62	12.45	0.34	1.21
Net Income to Common	2.51	2.24	1.62	12.45	0.34	1.21
Net Income Growth	-	37.62%	-86.96%	3605.36%	-72.30%	-25.22%
Shares Outstanding (Basic)	14	14	14	10	8	8
Shares Outstanding (Diluted)	14	14	14	10	8	8
Shares Change (YoY)	0.47%	-	40.20%	20.61%	-	-
EPS (Basic)	0.18	0.16	0.12	1.25	0.04	0.15
EPS (Diluted)	0.18	0.16	0.12	1.25	0.04	0.15
EPS Growth	-	37.44%	-90.69%	3025.00%	-72.80%	-25.22%
Free Cash Flow	-17.55	-13.57	-74.22	-16.88	2.09	-10.02
Free Cash Flow Per Share	-1.26	-0.97	-5.32	-1.70	0.25	-1.21
Gross Margin	6.51%	8.91%	17.55%	41.13%	19.98%	22.87%
Operating Margin	2.99%	4.61%	4.34%	19.70%	4.91%	5.15%
Profit Margin	1.26%	1.51%	1.03%	10.09%	0.30%	1.03%
Free Cash Flow Margin	-8.78%	-9.16%	-46.96%	-13.68%	1.86%	-8.55%
EBITDA	7.02	7.87	8.17	25.98	7.7	8.6
EBITDA Margin	3.51%	5.31%	5.17%	21.05%	6.86%	7.34%
D&A For EBITDA	1.05	1.04	1.3	1.68	2.19	2.57
EBIT	5.97	6.83	6.87	24.3	5.51	6.03
EBIT Margin	2.99%	4.61%	4.34%	19.70%	4.91%	5.15%
Effective Tax Rate	27.47%	26.91%	27.85%	30.12%	24.83%	24.75%
Revenue as Reported	202.33	152.78	161.29	123.37	112.19	117.19
Advertising Expenses	-	-	0.03	-	0.08	0.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.